The aim of our study was to investigate the efficacy of Bryophyllum pinnatum leaves ethanol extract in pristane-induce systemic lupus erythematosus (SLE) BALB/c mice model. Forty female BALB/c mice, aged 6-8 weeks old received a single i.p. injection of 0.5 cc pristane for lupus induction. 16 weeks after injection, pristane-induced lupus mice were divided into four groups based on the doses of Bryophyllumpinnatum received intragastrically: 0, 10.5 mg/kg/, 21 mg/kg/, and 42 mg/kg/day for 12 weeks. At 38 weeks after injection, all mice were assessed for inflammation marker. Side effects study results suggest that there were no signs of side effects generally. No significant changes of blood pressure, liver and mice renal function were observed. The efficacy study showed that percentages of matured B cells, TNF-α, CRP, IL-17, and IL-12 decreased (p<0.05) and percentages of TGF-β and complement C3 and C4 increased (p>0.05) in Bryophyllum pinnatum treated mice. Bryophyllum pinnatum crude extract has the potential to be further developed as a new, safe, and effective agent of delivery to modulate immune cells against pristane-induced SLE BALB/c mice.

1.
Carlucci
,
F.
,
Ishaque
,
A.
,
Ling
,
G.S.
,
Szajna
,
M.
,
Sandison
,
A.
,
Donatien
,
P.
, et al 
C1q Modulates the Response to TLR7 Stimulation by Pristane-Primed Macrophages: Implications for Pristane-Induced Lupus
.
The Journal of Immunology.
2016
Feb 15:
196
(
4
):
1488
1494
.
2.
Barnes
,
E. V.
,
S.
Narain
,
A.
Naranjo
,
J.
Shuster
,
M. S.
Segal
, et al 
High Sensitivity C Reactive Protein in Systemic Lupus Erythematosus: Relation to Disease Activity, Clinical Presentation, and Implications for Cardiovascular Risk
.
Lupus.
2005
.
14
(
8
):
576
582
.
3.
Liu
,
Z.
,
Davidson
,
A.
BAFF and selection of autoreactive B cells
.
Trends Immunol.
2011
Aug:
32
(
8
):
388
394
.
4.
Furie
,
R. A.
,
Leon
,
G.
,
Thomas
,
M.
,
Petri
,
M. A.
,
Chu
,
A. D.
,
Hislop
,
C.
, et al 
A phase 2, randomised, placebo-controlled clinical trial of blisibimod, an inhibitor of B cell activating factor, in patients with moderate-tosevere systemic lupus erythematosus, the PEARL-SC study
.
Ann Rheum Dis.
2015
Sep:
74
(
9
):
1667
1675
.
5.
Jianxin
,
L.
,
Bonnie
,
K.C.
,
Cheukchun
,
S.
Update on the Role of T Cell Subset in the Pathogenesis of Systemic Lupus Erythematosus
.
Journal of Chinese Clinical Medicine
,
2009
,
4
:
400
409
.
6.
Ahmadpoor
,
P.
,
Dalili
,
N.
,
Rostami
,
M.
An Update on Pathogenesis of Systemic Lupus Erythematosus
.
Iranian Journal of Kidney Diseases.
2014
May:
8
(
3
):
171
184
.
7.
Abbas
,
A.K.
,
Lichtman
,
A.H.
,
Pillai
,
S.
,
Basic Immunology: Functions and Dysorders of the Immune System
, 5th Ed.,
Elsevier
,
Canada
,
2016
.
8.
Manolova
,
I.
,
Gerenova
,
J.
,
Ivanova
,
M.
Serum Levels of Transforming Growth Factor-β1 (TGF-β1) in Patients with Systemic Lupus Erythematosus and Hashimoto’s Thyroiditis
.
European Cytokine Network.
2013
Mar:
24
(
1
):
69
74
.
9.
Cruz
,
E. A.
,
Reuter
,
S.
,
Martin
,
H.
,
Dehzad
,
N.
,
Muzitano
,
M. F.
,
Costa
,
S. S.
Kalanchoe pinnata inhibits mast cell activation and prevents allergic airway disease
.
Phytomedicine.
2012
Jan 15:
19
(
2
):
115
121
.
10.
Leiss
,
H.
,
Niederreiter
,
B.
,
Bandur
,
T.
,
Schwarzecker
,
B.
,
Blümi
,
S.
,
Steiner
,
G.
, et al 
Pristane-induced lupus as a model of human lupus arthritis: evolvement of autoantibodies, internal organ and joint inflammation
.
Lupus.
2013
Jul:
22
(
8
):
778
792
.
11.
Metawie
,
S.A.
,
ElRefai
,
R.M.
,
ElAdle
,
S.S.
,
Shahin
,
R.M.H.
Transforming Growth Factor-β1 in Systemic Lupus Erythematosus Patients and Its Relation to Organ Damage and Disease Activity
.
The Egyptian Rheumatologist.
2015
Feb 3:
37
(
4
):
49
54
.
12.
Cruz
,
E. A.
,
Da Silva
,
S. A.
,
Muzitano
,
M.F.
,
Silva
,
P.M.
,
Costa
,
S. S.
,
Rossi-Bergmann
,
B.
Immunomodulatory pretreatment with Kalanchoe pinnata extract and its quercitrin flavonoid effectively protects mice against fatal anaphylactic shock
.
Int Immunopharmacol.
2008
Dec 10:
8
(
12
):
1616
1621
.
13.
Indriyanti
,
Niken
&
Soeroso
,
Joewono
&
Khotib
,
Junaidi
.
The benefits of active compounds in Kalanchoe Pinnata (LMK) pers ethyl acetate fraction on lupus arthritis mice
.
Asian Journal of Pharmaceutical and Clinical Research.
2017
Nov:
10
(
11
):
199
.
14.
Nurdiana
,
N.
,
Sari
,
Y.
,
Wahyuni
,
R.
,
Maya
,
A.
,
Syukur
,
N. A.
,
Dewi
,
E. S.
, et al 
Immunomodulation Effects of Bryophyllum Pinnatum on Pregnant Pristane-Induced Lupus Mice Model
.
Research Journal of Life Science.
2016
:
3
(
3
):
190
200
.
15.
Ojewole
JA
.
P-2: Antihypertensive properties of Bryophyllum pinnatum {(Lam) Oken} leaf extracts
.
American Journal of Hypertension.
2002
Apr 1;
15
(
S3
):
34A
16.
Al-Snafi
A.E.
The Chemical Constituents and Pharmacological Effects of Bryophyllum Calycinum. A review
.
International Journal of Pharma Sciences and Research.
2014
Jan:
4
(
12
):
171
174
.
17.
Davidson
A.
(
2015
).
What is damaging the kidney in lupus nephritis?
.
Nature Reviews Rheumatology.
2016
Mar:
12
(
3
):
143
153
.
18.
Potter
M
,
Sklar
MD
,
Rowe
WP
.
Rapid viral induction of plasmacytomas in pristane-primed BALB/c mice
.
Science.
1973
Nov 9;
182
(
4112
):
592
594
.
19.
Duarte-García
A
,
Barr
E
,
Magder
LS
,
Petri
M.
Predictors of incident proteinuria among patients with SLE
.
Lupus Science&Medicine.
2017
Jan 6:
4
(
1
):
1
7
.
20.
Indriyanti
N
,
Garmana
AN
,
Setiawan
F.
Repairing Effects of Aqueous Extract of Kalamnchoe pinnata (Lmk) Pers. on Lupus Nephritis Mice
.
Pharmacognosy Journal.
2018
Mar:
10
(
3
):
548
552
.
21.
Rajsekhar
PB
,
Arvind Bharani
RS
,
Ramachandran
M
,
Angel
JK
,
Rajsekhar
SPV
.
The “Wonder Plant” Kalanchoe pinnata (Linn.) Pers.: A Review
.
Journal of Applied Pharmaceutical Science.
2016
Mar:
6
(
3
):
151
158
.
This content is only available via PDF.
You do not currently have access to this content.